Latest News
Medical materials manufacturer Camstent has raised GBP850,000 from a combination of existing and new investors in its latest funding round.
Thanks to interest in the company’s patented bacteria-phobic polymer coatings, the initial investment target of GBP300,000 was extended, nearly trebling the total amount raised during the round.
Currently one in 20 inpatients suffer from a hospital acquired infection (HAI), leading to the loss of thousands of lives globally and adding to costs for healthcare providers.
Government research found that a 10 per cent reduction in infections could save the NHS GBP100 million per annum.
Camstent’s patented bacteria-phobic
- 07/09/2016
- 07/09/2016
Bedell Cristin has appointed Kate Ovenden as managing partner in the firm’s Guernsey office.
An experienced corporate, banking and financial services lawyer who spent 10 years working at City law firm Withers, Ovenden (pictured) became a partner of Bedell Cristin in 2010, having returned to Guernsey to join the firm in 2006.
Ovenden also has extensive experience in advising all types of clients on banking, funds, corporate and commercial matters.
Advocate Mark Helyar, the former managing partner, will remain with the firm in an of counsel role.
Helyar, who has led the Guernsey office since it first
- 07/09/2016
Elm Capital says it has seen a strong first half with primary fund closings and secondary transactions for many of its clients in Europe and North America.
On 26 July, Montefiore Investment completed the first and final closing of its largely oversubscribed fourth fund at the agreed hard cap of EUR420 million of third party capital, exceeding its EUR350 million target.
This result was achieved within just three months due to a particularly efficient process by virtue of strong support from existing and new investors. More than 20 new institutional investors committed to the fund.
With its fourth
- 07/09/2016
Pavilion Financial has closed its acquisition of Altius Holdings, the parent company of Altius Associates, a private markets advisory and separate account management firm with offices in the UK, US and Singapore.
Pavilion has also established Pavilion Alternatives Group, a combination of the operations of Altius Associates and LP Capital Advisors (LPCA), the alternative asset advisory subsidiary of Pavilion headquartered in Sacramento, California.
The rebranding for both organisations is effective immediately.
“Pavilion Alternatives Group will proudly carry forward the shared vision of its two founding firms to provide institutional clients with objective, thoughtful and well-researched advice on alternative
- 07/09/2016
Ufenau IV, a fund advised by Ufenau Capital Partners, has sold its shares in Roth Brandschutz to Equistone Partners Europe, realising a 4x cash return and an IRR of 108 per cent.
Roth Group is headquartered in Gerlafingen, Switzerland, and offers its clients fire protection, insulation and coatings services.
Since partnering with Ufenau, Roth Group has grown the business considerably and increased revenues by 70 per cent to CHF65 million. The number of employees increased from 220 to 350 and Roth Group became Switzerland's largest service provider in its market segments.
In close collaboration with Ufenau, Roth Group completed
- 07/09/2016
- 07/09/2016
TPG Capital, the global private equity platform of alternative asset firm TPG, has appointed Jack Daly as a partner.
Daly most recently served as a partner and managing director in the principal investment area (PIA) of the merchant banking division at Goldman Sachs Group, leading the US industrials private equity team.
In his new role, Daly will be a sector leader with a focus on TPG Capital’s investments in the industrials space. He will be based in San Francisco.
“Jack’s experience as an investor and director in a variety of global industrial and technology businesses will be a
- 07/09/2016
- 07/09/2016
Praesidian Capital, a provider of senior and subordinated capital for small and mid-sized businesses, has exited its first-lien debt investment in Aquasana, a Texas-based provider of residential water filtration systems and replacement cartridges.
Praesidian’s debt investment supplemented an equity investment by L Catterton, the largest consumer-focused private equity firm in the world.
Aquasana was acquired in August 2016 by A O Smith Corporation, a manufacturer of residential and commercial water treatment systems, heaters and boilers.
Praesidian’s 2015 investment in Aquasana provided capital to support the company’s vision for strategic growth. With this additional funding, Aquasana was able to
- 07/09/2016
Castanea Partners has appointed Tom First as an operating partner focusing on opportunities in the branded food and beverage sector.
“We are thrilled that Tom will be joining our team,” says Brian Knez, managing partner of Castanea. “Tom is an extraordinarily successful serial entrepreneur, advisor, and investor. His deep passion and experience in the food and beverage space will bring a unique perspective to our existing portfolio and help us identify exciting new investment opportunities.”
Prior to joining Castanea, First was a managing partner at First Beverage Ventures, the investment arm of First Beverage Group.
He was also
- 07/09/2016
Calculus Capital is to make a GBP3 million investment in drug discovery engine C4X Discovery, becoming a cornerstone investor in a GBP5 million AIM fundraising, scheduled for admission to the market on 27 September.
The money will be used to progress C4X’s existing pipeline of pre-clinical drug design and development for use in the treatment of a wide range of diseases and medical conditions.
John Glencross, chief executive of Calculus Capital, says: “C4X Discovery aims to become the world’s most productive drug discovery and development company. That is no small ambition but we believe its patented drug discovery platform, Conformetrix, and revolutionary
- 07/09/2016
Bryan, Garnier & Co has advised Adents, a provider of serialisation and traceability software, on a EUR12 million series C funding round, bringing the total amount raised by the company to EUR20 million in 18 months.
Pharmaceutical counterfeiting has been booming globally. Law and regulations requiring unit tracking and tracing of drugs packages have been issued in the US and in Europe.
Over the last few years, Adents has provides easily deployable serialisation and track-and-trace software solutions for the pharmaceutical and life sciences industries.
Serialisation is a way of ascribing small batches or even single packages individual identification
- 07/09/2016
Special Reports
Featured
- Intel
- May 17, 2024
- Awards
- May 16, 2024
- Intel
- May 16, 2024
- Intel
- May 15, 2024
- Intel
- May 13, 2024
Events
16 May, 2024 – 5:30 pm
05 June, 2024 – 8:30 am
12 September, 2024 – 8:30 am
12 September, 2024 – 6:00 pm
